XWELL, Inc. (XWEL)

Market Cap	10.22M +122.1%
Revenue (ttm)	28.83M -10.5%
Net Income	-34.13M
EPS	-5.60
Shares Out	8.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150,709
Open	1.220
Previous Close	1.200
Day's Range	1.180 - 1.290
52-Week Range	0.255 - 2.200
Beta	1.01
Analysts	Buy
Price Target	7.00 (+478.51%)
Earnings Date	May 20, 2026

About XWEL

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler’s spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircra...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 280
• Stock Exchange: NASDAQ
• Ticker Symbol: XWEL
• Website: https://www.xwell.com

Financial Performance

In 2025, XWELL's revenue was $29.21 million, a decrease of -13.83% compared to the previous year's $33.90 million. Losses were -$28.23 million, 67.5% more than in 2024.

Analyst Summary

According to one analyst, the rating for XWEL stock is "Buy" and the 12-month stock price target is $7.0.

Price Target

$7.0

(478.51% upside)

Analyst Consensus: Buy